| Title | AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke (ARCADIA) |
|---|---|
| Disease/Condition | Heart and Vascular Diseases,Brain and Neurological,Neurology,Stroke and Cerebrovascular Diseases |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Kathryn Kirchoff-Torres, MD |
| Contact Name | Khadean Moncrieffe |
| Contact Email | kmoncrie@montefiore.org |
| Protocol Number | 2017-8507 |
| Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | Neurology |
| Adult, Pediatric, Both | Adult |